Dunja Lukovic

Dr. Dunja Lukovic


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
DLDunja Lukovic
Dunja Lukovic
ACAna Artero Castro
Ana Artero Castro
KKKoray Dogan Kaya
Koray Dogan Kaya
DMDaniella Munezero
Daniella Munezero
LGLinn Gieser
Linn Gieser
SESlaven Erceg
Slaven Erceg
Aryl hydrocarbon receptor-interacting protein-like 1 (AIPL1) is a photoreceptor-specific chaperone that stabilizes the effector enzyme of phototransduction, cGMP phosphodiesterase 6 (PDE6). Mutations in the AIPL1 gene cause a severe inherited retinal dystrophy, Leber congenital amaurosis type 4 (LCA4), that manifests as the loss of vision during the first year of life. In this study, we generated three-dimensional (3D) retinal organoids (ROs) from human induced pluripotent stem cells (hiPSCs) derived from an LCA4 patient carrying a Cys89Arg mutation in AIPL1. This study aimed to (i) explore whether the patient hiPSC-derived ROs recapitulate LCA4 disease phenotype, and (ii) generate a clinically relevant resource to investigate the molecular mechanism of disease and safely test novel therapies for LCA4 in vitro. We demonstrate reduced levels of the mutant AIPL1 and PDE6 proteins in patient organoids, corroborating the findings in animal models; however, patient-derived organoids maintained retinal cell cytoarchitecture despite significantly reduced levels of AIPL1.

29 April 2021 in Frontiers in Neuroscience
Verified
Journal Article
Open access
PDF file
ÁAÁngeles Arzalluz-Luque
Ángeles Arzalluz-Luque
JCJose Luis Cabrera
Jose Luis Cabrera
HSHeli Skottman
Heli Skottman
ABAlberto Benguria
Alberto Benguria
ABArantxa Bolinches-Amorós
Arantxa Bolinches-Amorós
DLDunja Lukovic
Dunja Lukovic
Retinitis pigmentosa (RP) is a rare, progressive disease that affects photoreceptors and retinal pigment epithelial (RPE) cells with blindness as a final outcome. Despite high medical and social impact, there is currently no therapeutic options to slow down the progression of or cure the disease. The development of effective therapies was largely hindered by high genetic heterogeneity, inaccessible disease tissue, and unfaithful model organisms. The fact that components of ubiquitously expressed splicing factors lead to the retina-specific disease is an additional intriguing question. Herein, we sought to correlate the retinal cell-type-specific disease phenotype with the splicing profile shown by a patient with autosomal recessive RP, caused by a mutation in pre-mRNA splicing factor 8 (PRPF8). In order to get insight into the role of PRPF8 in homeostasis and disease, we capitalize on the ability to generate patient-specific RPE cells and reveal differentially expressed genes unique to RPE cells. We found that spliceosomal complex and ribosomal functions are crucial in determining cell-type specificity through differential expression and alternative splicing (AS) and that PRPF8 mutation causes global changes in splice site selection and exon inclusion that particularly affect genes involved in these cellular functions. This finding corroborates the hypothesis that retinal tissue identity is conferred by a specific splicing program and identifies retinal AS events as a framework toward the design of novel therapeutic opportunities.

1 April 2018 in Stem Cell Research
Verified
Journal Article
Open access
ACAna Artero Castro
Ana Artero Castro
MLMarian León
Marian León
VFVerónica del Buey Furió
Verónica del Buey Furió
SESlaven Erceg
Slaven Erceg
DLDunja Lukovic
Dunja Lukovic
The human iPSC cell line, derived from foreskin fibroblasts was generated by non-integrative, non-viral reprogramming technology using OCT4, SOX2, KLF4, LIN28, c-MYC mRNAs.

1 July 2019 in Stem Cell Research
Verified
Journal Article
Open access
ABArantxa Bolinches-Amorós
Arantxa Bolinches-Amorós
MLMarian León
Marian León
VFVerónica del Buey Furió
Verónica del Buey Furió
GMGemma Marfany
Gemma Marfany
RGRoser Gonzàlez-Duarte
Roser Gonzàlez-Duarte
DLDunja Lukovic
Dunja Lukovic
Dermal fibroblasts from an autosomal recessive retinitis pigmentosa (RP) patient, homozygous for the mutation c.769 C>T, p.Arg257Ter, in CERKL (Ceramide Kinase-Like) gene, and a healthy sibling were derived and reprogrammed by Sendai virus. The generated human induced pluripotent stem cell (hiPSC) lines RP3-FiPS4F1 and Ctrl3-FiPS4F1, were free of genomically integrated reprogramming genes, showed stable karyotypes, expressed pluripotency markers and could be differentiated towards the three germ layers in vitro. These hiPSC lines offer a useful resource to study RP pathomechanisms, drug testing and therapeutic opportunities.

1 December 2018 in Stem Cell Research
Verified
Journal Article
Open access
PDF file
DLDunja Lukovic
Dunja Lukovic
ACAna Artero Castro
Ana Artero Castro
MLMarian León
Marian León
VFVerónica del Buey Furió
Verónica del Buey Furió
MCMarta Corton
Marta Corton
ESErceg Slaven
Erceg Slaven
The human induced pluripotent stem cell (hiPSC) line, derived from dermal fibroblasts from Leber congenital amaurosis patient with homozygous mutation c.265 T > C, p.Cys89Arg in aryl hydrocarbon receptor-interacting protein-like 1 (AIPL1) was generated by Sendai virus reprogramming. The generated hiPSC line was free of Sendai virus genes, had stable karyotype, carried the homozygous mutation, was immunopositive to pluripotency markers and able to generate all three germ layers upon embryoid body formation.

1 May 2017 in Stem Cell Research
Verified
Journal Article
Open access
DLDunja Lukovic
Dunja Lukovic
ABArantxa Bolinches-Amorós
Arantxa Bolinches-Amorós
AAAna Artero-Castro
Ana Artero-Castro
BPBeatriz Pascual
Beatriz Pascual
MCMiguel Carballo
Miguel Carballo
ESErceg Slaven
Erceg Slaven
The human iPSC cell line, RP2-FiPS4F1 (RCPFi001-A), derived from dermal fibroblasts from the patient with retinitis pigmentosa caused by the mutation of the gene PRPF8, was generated by non-integrative reprogramming technology using OCT3/4, SOX2, CMYC and KLF4 reprogramming factors.